Futura Medical (LON:FUM) Stock Price Up 11.1% – Here’s What Happened

Shares of Futura Medical plc (LON:FUM) rose 11.1% during mid-day trading on Thursday . The company traded as high as GBX 0.40 and last traded at GBX 0.40. Approximately 8,094,989 shares were traded during trading, a decline of 5% from the average daily volume of 8,524,908 shares. The stock had previously closed at GBX 0.36.

Futura Medical Stock Up 11.1%

The firm has a 50 day moving average price of GBX 0.60 and a 200 day moving average price of GBX 1. The stock has a market capitalization of £2.33 million, a PE ratio of -0.14 and a beta of 0.02.

Futura Medical (LON:FUM) last announced its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The company had revenue of GBX 170 million for the quarter. On average, equities analysts forecast that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.